Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | NTSR1 | P30989 | 14/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 13/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 12/20 | 0.46 |
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30532202 | 0.87 | XIAP (0.53) | XIAPNTSR1NTSR2SORT1PTPN1 | |
| SCHEMBL30052704 | 0.86 | XIAP (0.77) | XIAP | |
| SCHEMBL29482768 | 0.85 | ACE (0.54) | XIAPACERENSLC6A2 | |
| SCHEMBL29350341 | 0.85 | ACE (0.54) | XIAPACERENSLC6A2 | |
| SCHEMBL29406315 | 0.84 | XIAP (0.53) | XIAPNTSR1NTSR2SORT1 | |
| SCHEMBL18613464 | 0.84 | XIAP (0.54) | XIAPNTSR1NTSR2ACEREN | |
| SCHEMBL30957175 | 0.84 | XIAP (0.51) | XIAPNTSR1NTSR2SORT1 | |
| SCHEMBL29531054 | 0.83 | SLC6A2 (0.47) | XIAPACERENSLC6A2PTPN1 | |
| SCHEMBL29352327 | 0.82 | XIAP (0.55) | XIAPACEREN | |
| SCHEMBL29974998 | 0.82 | ACE (0.49) | XIAPACERENSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109219436-B | Modified wound dressing | 康沃特克科技公司 | 2025-05-23 | — | — | CN | disclosed |
| US-12265082-B2 | Detecting microbial infection in wounds | SYNOVO GMBH (DE) | 2025-04-01 | — | — | US | disclosed |
| US-12257323-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES, INC. | 2024-04-18 | — | — | US | disclosed |
| US-20240027454-A1 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2024-01-25 | — | — | US | disclosed |
| US-11865192-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| EP-3436012-B1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC (US) | 2023-09-20 | — | — | EP | disclosed |
| US-11740241-B2 | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds | SYNOVO GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| CN-109564213-B | Detecting microbial wound infection | 西诺福有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-109564213-A | Detecting microbial wound infection | 西诺福有限公司 | 2019-04-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | XIAP 520/4885NTSR1 3668/4885NTSR2 3999/4885 |
| US-11865192-B2 | Modified wound dressings | MMP8, CD68, ELANE | XIAP 520/4885NTSR1 3668/4885NTSR2 3999/4885 |
| US-12257323-B2 | Modified wound dressings | MMP8, CD68, ELANE | XIAP 520/4885NTSR1 3668/4885NTSR2 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.